71 related articles for article (PubMed ID: 6273277)
1. Heterogeneous forms of thyroid-stimulating hormone in mouse thyrotropic tumor and serum: differences in receptor-binding and adenylate cyclase-stimulating activity.
Pekonen F; Carayon P; Amr S; Weintraub BD
Horm Metab Res; 1981 Nov; 13(11):617-20. PubMed ID: 6273277
[TBL] [Abstract][Full Text] [Related]
2. Diminished binding of thyroid-stimulating hormone in a transplantable rat thyroid tumor as a possible cause of hormone unresponsiveness.
Mandato E; Meldolesi MF; Macchia V
Cancer Res; 1975 Nov; 35(11 Pt 1):3089-93. PubMed ID: 171062
[TBL] [Abstract][Full Text] [Related]
3. Thyrotropin receptor-adenylate cyclase function in human thyroid neoplasms.
Saltiel AR; Powel-Jones CH; Thomas CG; Nayfeh SN
Cancer Res; 1981 Jun; 41(6):2360-5. PubMed ID: 6263464
[TBL] [Abstract][Full Text] [Related]
4. Extraction and characterization of a thyrotropic material from the human placenta.
Hershman JM; Starnes WR
J Clin Invest; 1969 May; 48(5):923-9. PubMed ID: 5813651
[TBL] [Abstract][Full Text] [Related]
5. Thyrotropin binding and adenylate cyclase stimulation in thyroid neoplasms.
Clark OH; Gerend PL; Cote TC; Nissenson RA
Surgery; 1981 Aug; 90(2):252-61. PubMed ID: 6266060
[TBL] [Abstract][Full Text] [Related]
6. Purification and properties of an Indian major carp (Cirrhinus mrigala, Ham.) pituitary thyrotropin.
Bandyopadhyay S; Bhattacharya S
Gen Comp Endocrinol; 1993 May; 90(2):192-204. PubMed ID: 8319876
[TBL] [Abstract][Full Text] [Related]
7. Naturally occurring forms of thyrotropin with low bioactivity and altered carbohydrate content act as competitive antagonists to more bioactive forms.
Joshi LR; Weintraub BD
Endocrinology; 1983 Dec; 113(6):2145-54. PubMed ID: 6641628
[TBL] [Abstract][Full Text] [Related]
8. Thyrotropin (TSH) receptor and adenylate cyclase activity in human thyroid tumors: absence of high affinity receptor and loss of TSH responsiveness in undifferentiated thyroid carcinoma.
Abe Y; Ichikawa Y; Muraki T; Ito K; Homma M
J Clin Endocrinol Metab; 1981 Jan; 52(1):23-8. PubMed ID: 6256403
[TBL] [Abstract][Full Text] [Related]
9. Thyrotropin regulation of adenylate cyclase activity in human thyroid neoplasms.
Clark OH; Gerend PL
Surgery; 1985 May; 97(5):539-46. PubMed ID: 2986305
[TBL] [Abstract][Full Text] [Related]
10. Receptor-specific activity of heteromeric thyrotropin (TSH) analogs: development of synthetic TSH antagonists.
Sheehan MT; Morbeck DE; Bergert ER; McCormick DJ; Milius RP; Morris JC
Pept Res; 1995; 8(5):264-71. PubMed ID: 8589548
[TBL] [Abstract][Full Text] [Related]
11. Increased high-molecular-weight thyrotropin with impaired biologic activity in a euthyroid man.
Spitz IM; Le Roith D; Hirsch H; Carayon P; Pekonen F; Liel Y; Sobel R; Chorer Z; Weintraub B
N Engl J Med; 1981 Jan; 304(5):278-82. PubMed ID: 6255331
[No Abstract] [Full Text] [Related]
12. Salmon thyroid-stimulating hormone: isolation, characterization, and development of a radioimmunoassay.
Moriyama S; Swanson P; Larsen DA; Miwa S; Kawauchi H; Dickhoff WW
Gen Comp Endocrinol; 1997 Dec; 108(3):457-71. PubMed ID: 9405122
[TBL] [Abstract][Full Text] [Related]
13. Polyphloretin phosphate, an antagonist of thyrotropin action: evidence for an interaction with the hormone rather than the receptor.
Amir SM; Kasagi K; Corretti M; Blank M; Ingbar SH
Endocrinology; 1985 Sep; 117(3):860-8. PubMed ID: 2990874
[TBL] [Abstract][Full Text] [Related]
14. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
Heyma P; Harrison LC
J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
[TBL] [Abstract][Full Text] [Related]
15. The effect of sialic acid on adenylate cyclase activity and thyrotropin-receptor binding in human thyroid membranes.
Adler GM
Acta Biochim Pol; 1978; 25(4):343-7. PubMed ID: 220831
[TBL] [Abstract][Full Text] [Related]
16. Thyrotropin receptor-adenylate cyclase system in Hurthle cell neoplasms.
Clark OH; Gerend PL
J Clin Endocrinol Metab; 1985 Oct; 61(4):773-8. PubMed ID: 2993348
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antiidiotypic antibodies interact with the 93 kilodalton thyrotropin receptor and exhibit heterogeneous biological activities.
Costagliola S; Ruf J; Durand-Gorde MJ; Carayon P
Endocrinology; 1991 Mar; 128(3):1555-62. PubMed ID: 1999172
[TBL] [Abstract][Full Text] [Related]
18. Solubilized TSH-receptor: its usefulness for the radioligand receptor assay for TSH and TSH-displacing antibody.
Kotulla P; Schleusener H
J Endocrinol Invest; 1981; 4(2):155-60. PubMed ID: 6268690
[TBL] [Abstract][Full Text] [Related]
19. Radioligand receptor assay for TSH and TSH-binding-inhibiting antibodies using solubilized TSH-receptor.
Kotulla P; Kostner C; Schleusener H
J Endocrinol Invest; 1983 Apr; 6(2):135-8. PubMed ID: 6134766
[TBL] [Abstract][Full Text] [Related]
20. Resolution of radioiodinated thyrotropin into receptor active and inactive components by column chromatography.
Powell-Jones CH; McQuade RD; Thomas CG; Nayfeh SN
Mol Cell Endocrinol; 1982; 28(3):275-87. PubMed ID: 6295838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
